UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure

Lupus, 2021-03, Vol.30 (3), p.403-411

2021

Volltextzugriff (PDF)

More than healthy bones: a review of vitamin D in muscle health

Therapeutic Advances in Musculoskeletal Disease, 2015-08, Vol.7 (4), p.152-159

2015

Volltextzugriff (PDF)

Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients

Osteoporosis international, 2024, Vol.35 (1), p.181-187

2024

Volltextzugriff (PDF)

Bisphosphonates: from softening water to treating PXE

Cell cycle (Georgetown, Tex.), 2015-05, Vol.14 (9), p.1354-1355

2015

Volltextzugriff (PDF)

Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years

Bone Reports, 2023-12, Vol.19, p.101715-101715, Article 101715

2023

Volltextzugriff (PDF)

Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis

Journal of bone and mineral metabolism, 2010-03, Vol.28 (2), p.233-239

2010

Volltextzugriff (PDF)

Reporting Fewer Than Four Vertebrae: 2023 Official Positions of the International Society for Clinical Densitometry

Journal of clinical densitometry, 2024-01, Vol.27 (1), p.101436-101436, Article 101436

2024

Volltextzugriff (PDF)

Reporting of Full-Length Femur Imaging to Detect Incomplete Atypical Femur Fractures: 2023 Official Positions of the International Society for Clinical Densitometry

Journal of clinical densitometry, 2024-01, Vol.27 (1), p.101439-101439, Article 101439

2024

Volltextzugriff (PDF)

Bilateral hip DXA Reporting: 2023 Official Positions of the International Society for Clinical Densitometry

Journal of clinical densitometry, 2024-01, Vol.27 (1), p.101438-101438, Article 101438

2024

Volltextzugriff (PDF)

Choosing a Treatment for Patients at the Time a Fracture is Presented

Current osteoporosis reports, 2011-09, Vol.9 (3), p.156-159

Tanner, S. Bobo

2011

Volltextzugriff (PDF)

Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical setting

Bone (New York, N.Y.), 2023-12, Vol.177, p.116925-116925, Article 116925

2023

Volltextzugriff (PDF)

DXA Reporting Updates: 2023 Official Positions of the International Society for Clinical Densitometry

Journal of clinical densitometry, 2024-01, Vol.27 (1), p.101437-101437, Article 101437

2024

Volltextzugriff (PDF)

Toward the use of MRI measurements of bound and pore water in fracture risk assessment

Bone (New York, N.Y.), 2023-11, Vol.176, p.116863-116863, Article 116863

2023

Volltextzugriff (PDF)

Duration of Treatment in Postmenopausal Osteoporosis: How Long to Treat and What are the Consequences of Cessation of Treatment?

Rheumatic diseases clinics of North America, 2011-08, Vol.37 (3), p.323-336

2011

Volltextzugriff (PDF)

A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology

Open Access Rheumatology, 2012-01, Vol.4 (default), p.99-107

2012

Volltextzugriff (PDF)

Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy

Journal of managed care & specialty pharmacy, 2021-07, Vol.27 (7), p.882-890

2021

Volltextzugriff (PDF)

In Memoriam: Elliott N. Schwartz, MD

Journal of clinical densitometry, 2022-01, Vol.25 (1), p.1-2

2022

Volltextzugriff (PDF)

Reversing Vascular Dysfunction in Rheumatoid Arthritis: Improved Augmentation Index but Not Endothelial Function With Peroxisome Proliferator–Activated Receptor γ Agonist Therapy

Arthritis & rheumatology (Hoboken, N.J.), 2014-09, Vol.66 (9), p.2331-2338

2014

Volltextzugriff (PDF)

Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial

Arthritis research & therapy, 2013-01, Vol.15 (5), p.R110-R110

2013

Volltextzugriff (PDF)

Evaluation of a Vitamin D Screening and Treatment Protocol Using a Seasonal Calculator in Athletes

Current sports medicine reports, 2022-02, Vol.21 (2), p.53-62

2022

Volltextzugriff (PDF)

Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Journal of clinical densitometry, 2011-07, Vol.14 (3), p.184

2011

Volltextzugriff (PDF)

Impact of omalizumab therapy on medication requirements for chronic rhinosinusitis

International forum of allergy & rhinology, 2016-05, Vol.6 (5), p.472-477

2016

Volltextzugriff (PDF)

Management of osteoporosis among home health and long-term care patients with a prior fracture

Southern medical journal (Birmingham, Ala.), 2009-04, Vol.102 (4), p.397-404

2009

Volltextzugriff (PDF)

Differential effect of omalizumab on pulmonary function in patients with allergic asthma with and without chronic rhinosinusitis

Allergy and asthma proceedings, 2016-01, Vol.37 (1), p.23-26

2016

Volltextzugriff (PDF)

Definition of Osteoporosis by Bone Density Criteria in Men: Effect of Using Female Instead of Male Young Reference Data Depends on Skeletal Site and Densitometer Manufacturer

Journal of clinical densitometry, 2014-04, Vol.17 (2), p.301-306

2014

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(55)
Berichte
(1)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure

More than healthy bones: a review of vitamin D in muscle health

Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients

Bisphosphonates: from softening water to treating PXE

Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years

Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis

Reporting Fewer Than Four Vertebrae: 2023 Official Positions of the International Society for Clinical Densitometry

Reporting of Full-Length Femur Imaging to Detect Incomplete Atypical Femur Fractures: 2023 Official Positions of the International Society for Clinical Densitometry

Bilateral hip DXA Reporting: 2023 Official Positions of the International Society for Clinical Densitometry

Choosing a Treatment for Patients at the Time a Fracture is Presented

Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical setting

DXA Reporting Updates: 2023 Official Positions of the International Society for Clinical Densitometry

Toward the use of MRI measurements of bound and pore water in fracture risk assessment

Duration of Treatment in Postmenopausal Osteoporosis: How Long to Treat and What are the Consequences of Cessation of Treatment?

A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology

Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy

In Memoriam: Elliott N. Schwartz, MD

Reversing Vascular Dysfunction in Rheumatoid Arthritis: Improved Augmentation Index but Not Endothelial Function With Peroxisome Proliferator–Activated Receptor γ Agonist Therapy

Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial

Evaluation of a Vitamin D Screening and Treatment Protocol Using a Seasonal Calculator in Athletes

Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX

Impact of omalizumab therapy on medication requirements for chronic rhinosinusitis

Management of osteoporosis among home health and long-term care patients with a prior fracture

Differential effect of omalizumab on pulmonary function in patients with allergic asthma with and without chronic rhinosinusitis

Definition of Osteoporosis by Bone Density Criteria in Men: Effect of Using Female Instead of Male Young Reference Data Depends on Skeletal Site and Densitometer Manufacturer

Suchergebnisse filtern